机构:[1]Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[2]Uro-Oncology Research Program, Samuel Oschin Comprehensive Cancer Institute, Department of Medicine, Cedars-Sinai Medical Center, 8750 Beverly Boulevard, Atrium 105, Los Angeles, CA, 90048, USA.[3]Division of Cancer Biology and Therapeutics, Departments of Surgery and Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.[4]Department of Pathology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.[5]Department of Urology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
This work was supported by NCI P01 CA098912 and the Board of Governors
Chair of Cancer Research Fund from Cedars-Sinai Medical Center to Leland W.
K. Chung.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|1 区医学
小类|2 区肿瘤学
最新[2023]版:
大类|1 区医学
小类|2 区肿瘤学
第一作者:
第一作者机构:[1]Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.[2]Uro-Oncology Research Program, Samuel Oschin Comprehensive Cancer Institute, Department of Medicine, Cedars-Sinai Medical Center, 8750 Beverly Boulevard, Atrium 105, Los Angeles, CA, 90048, USA.
通讯作者:
推荐引用方式(GB/T 7714):
Yin Lijuan,Li Qinlong,Mrdenovic Stefan,et al.KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway.[J].Breast cancer research : BCR.2022,24(1):7.doi:10.1186/s13058-022-01502-6.
APA:
Yin Lijuan,Li Qinlong,Mrdenovic Stefan,Chu Gina Chia-Yi,Wu Boyang Jason...&Chung Leland W K.(2022).KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway..Breast cancer research : BCR,24,(1)
MLA:
Yin Lijuan,et al."KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway.".Breast cancer research : BCR 24..1(2022):7